创业慧康(300451) - 2025 Q3 - 季度财报

Financial Performance - Revenue for Q3 2025 was CNY 285,009,476.73, a decrease of 35.50% year-over-year, and a decrease of 26.26% year-to-date [3]. - Net profit attributable to shareholders was a loss of CNY 41,669,455.71, down 264.20% year-over-year, and a loss of CNY 122,224,175.50 year-to-date, down 331.69% [3]. - Basic and diluted earnings per share were both CNY -0.03, reflecting a decrease of 250.00% year-over-year [3]. - Total operating revenue for the period was ¥861,687,740.98, a decrease of approximately 26.2% from ¥1,168,619,942.05 in the previous period [25]. - The net profit for the period was a loss of ¥106,750,444.48, compared to a profit of ¥58,948,817.27 in the same period last year [27]. - Total comprehensive income for the period was -107,058,105.79 CNY, compared to 58,589,463.68 CNY in the previous period [28]. - Basic and diluted earnings per share were both -0.08 CNY, down from 0.03 CNY in the previous period [28]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,487,658,950.00, a decrease of 3.18% compared to the end of the previous year [3]. - Total assets decreased to ¥5,487,658,950.00 from ¥5,668,132,706.72, representing a decline of approximately 3.2% [24]. - Current liabilities totaled ¥1,101,603,924.13, down from ¥1,182,115,391.60, indicating a reduction of about 6.8% [24]. - The company reported a 43.45% decrease in current liabilities due to cost reduction and office consolidation efforts [7]. - The total equity attributable to shareholders decreased to ¥4,305,619,229.60 from ¥4,419,247,940.16, reflecting a decrease of about 2.6% [24]. Cash Flow - Cash flow from operating activities year-to-date was CNY -205,443,881.78, a decrease of 1.73% [3]. - Cash inflow from operating activities was 870,344,566.09 CNY, a decrease of 6.34% from 929,389,713.78 CNY in the previous period [29]. - Net cash flow from operating activities was -205,443,881.78 CNY, slightly worse than -201,946,282.20 CNY in the previous period [29]. - Cash inflow from investing activities totaled 991,469,974.58 CNY, significantly higher than 276,760,757.45 CNY in the previous period [31]. - Net cash flow from investing activities was -82,166,120.37 CNY, an improvement from -180,504,403.53 CNY in the previous period [31]. - Cash inflow from financing activities was 59,887,766.67 CNY, compared to 7,300,000.00 CNY in the previous period [31]. - Net cash flow from financing activities was 7,375,623.38 CNY, recovering from -17,568,142.06 CNY in the previous period [31]. - The ending balance of cash and cash equivalents was 735,712,921.09 CNY, up from 687,407,670.58 CNY in the previous period [31]. - The company's cash and cash equivalents decreased to ¥736,996,627.48 from ¥1,018,894,565.64, a decline of approximately 27.7% [22]. Income and Expenses - Total operating costs amounted to ¥889,664,255.47, down from ¥1,006,634,936.64, reflecting a reduction of about 11.6% [25]. - Research and development expenses increased to ¥223,500,790.80, up 20.5% from ¥185,412,536.45 in the previous period [27]. - The company reported a significant increase in investment income to ¥4,437,239.99 from ¥1,466,654.85, marking a growth of approximately 202.5% [27]. - The company's financial expenses improved, showing a reduction to -¥5,319,288.62 from -¥30,568,333.70, indicating a positive change in financial management [27]. Operational Highlights - The company secured a total of 24 orders worth over ten million RMB, with a year-on-year increase of 20% in order quantity and 7% in order value [18]. - The company successfully completed 16 HI-HIS project launches, with 75% of these projects being in tertiary hospitals [18]. - The company faced operational pressures due to delayed customer demand and postponed bidding processes, leading to revenue contraction [18]. - The company was recognized as a "scene-based digital service provider" by the Zhejiang Provincial Economic and Information Technology Department for 2025 [18]. - The AI application for key patient tracking (APTS) was included in the 2025 "Smart Products" list in Zhejiang Province, enhancing early detection and intervention capabilities for major diseases [18]. - The company completed the core system launch for Suzhou Municipal Hospital, marking the full completion of the information project for a large medical group with 5,000 beds [19]. - The company plans to continue strengthening its development support and operational capabilities to enhance project delivery efficiency [19]. - The company is optimistic about the future, citing strong core business prospects and continuous customer demand [19]. - The company approved the 2025 employee stock ownership plan, with shares sourced from the company's repurchase account for A-shares [19]. Other Information - Cash received from tax refunds increased by CNY 7,196,400.00 year-over-year, mainly due to an increase in VAT refunds [9]. - Cash paid for fixed assets decreased by 38.19% year-over-year, due to the completion of a project in the previous year [10]. - The third quarter financial report was not audited [32].